ABIO logo

ARCA Biopharma (ABIO) Total Assets

Annual Total Assets

$37.86 M
-$5.22 M-12.12%

December 31, 2023

Summary

Performance

1-Year Change

-12.12%

3-Year Change

-24.92%

5-Year Change

+454.74%

15-Year Change

+206.19%

ABIO Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$184.41 M
ABIO annual total assets is currently -79.47% below its historical high of $184.41 million

3-Year Low

$37.86 M
ABIO annual total assets is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ABIO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ABIO next annual earnings announcement has not yet been scheduled

OtherABIObalance sheetmetrics:

Annual Current Assets

$37.43 M
ABIO annual total current assets is $37.43 million

Annual Non Current Assets

$430.00 K
ABIO annual long term assets is $430.00 thousand

Annual Total Liabilities

$841.00 K
ABIO annual total liabilities is $841.00 thousand

Annual Current Liabilities

$637.00 K
ABIO annual total current liabilities is $637.00 thousand

Quarterly Total Assets

$33.84 M
-$2.86 M-7.80%

June 30, 2024

Summary

Performance

3-Month Change

-7.8%

1-Year Change

-10.61%

3-Year Change

-43.77%

5-Year Change

-43.77%

ABIO Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$248.09 M
ABIO quarterly total assets is currently -86.36% below its historical high of $248.09 million

3-Year Low

$33.84 M
ABIO quarterly total assets is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
ABIO previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
ABIO next earnings announcement has not yet been scheduled

OtherABIObalance sheetmetrics:

Quarterly Current Assets

$33.82 M
ABIO quarterly total current assets is $33.82 million

Quarterly Non Current Assets

$24.00 K
ABIO quarterly long term assets is $24.00 thousand

Quarterly Total Liabilities

$1.27 M
ABIO quarterly total liabilities is $1.27 million

Quarterly Current Liabilities

$1.27 M
ABIO quarterly total current liabilities is $1.27 million

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

Annual Total Assets

$37.86 M
ABIO annual total assets is $37.86 million

Annual Non Current Assets

$430.00 K
ABIO annual long term assets is $430.00 thousand

Annual Current Assets

$37.43 M
ABIO annual total current assets is $37.43 million

ABIO Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-12.1%-10.6%
3 y3 years-24.9%-43.8%
5 y5 years+454.7%-43.8%

ABIO Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-31.1%at low-38.4%at low
5 y5-year-31.1%-77.5%-51.1%-78.0%
alltimeall time-79.5%-91.5%-86.4%-90.5%

ARCA Biopharma Total Assets History

DateAnnualQuarterly
Jun 2024
-
$33.84 M(-7.8%)
Mar 2024
-
$36.71 M(-3.1%)
Dec 2023
$37.86 M(-12.1%)
$37.86 M(-3.4%)
Sep 2023
-
$39.18 M(-4.6%)
Jun 2023
-
$41.08 M(-2.3%)
Mar 2023
-
$42.06 M(-2.4%)
Dec 2022
$43.09 M(-21.6%)
$43.09 M(-4.2%)
Sep 2022
-
$44.97 M(-6.5%)
Jun 2022
-
$48.10 M(-5.7%)
Mar 2022
-
$51.01 M(-7.1%)
Dec 2021
$54.92 M(+8.9%)
$54.92 M(-8.8%)
Sep 2021
-
$60.19 M(-7.9%)
Jun 2021
-
$65.34 M(-5.6%)
Mar 2021
-
$69.18 M(+37.2%)
Dec 2020
$50.43 M(+490.8%)
$50.43 M(-3.0%)
Sep 2020
-
$51.98 M(+346.8%)
Jun 2020
-
$11.63 M(+55.9%)
Mar 2020
-
$7.46 M(-12.6%)
Dec 2019
$8.54 M(+25.1%)
$8.54 M(-14.2%)
Sep 2019
-
$9.95 M(-4.2%)
Jun 2019
-
$10.39 M(+20.7%)
Mar 2019
-
$8.61 M(+26.1%)
Dec 2018
$6.83 M(-44.8%)
$6.83 M(-19.2%)
Sep 2018
-
$8.45 M(-16.1%)
Jun 2018
-
$10.07 M(-21.3%)
Mar 2018
-
$12.79 M(+3.4%)
Dec 2017
$12.37 M(-49.8%)
$12.37 M(-26.9%)
Sep 2017
-
$16.92 M(-2.2%)
Jun 2017
-
$17.30 M(-16.0%)
Mar 2017
-
$20.59 M(-16.4%)
Dec 2016
$24.63 M(-37.8%)
$24.63 M(-14.1%)
Sep 2016
-
$28.68 M(-12.1%)
Jun 2016
-
$32.63 M(-11.6%)
Mar 2016
-
$36.93 M(-6.7%)
Dec 2015
$39.57 M(+145.3%)
$39.57 M(-6.7%)
Sep 2015
-
$42.40 M(-6.0%)
Jun 2015
-
$45.12 M(+240.2%)
Mar 2015
-
$13.26 M(-17.8%)
Dec 2014
$16.13 M(-5.6%)
$16.13 M(-10.6%)
Sep 2014
-
$18.04 M(-12.2%)
Jun 2014
-
$20.54 M(-9.3%)
Mar 2014
-
$22.66 M(+32.6%)
Dec 2013
$17.08 M(+431.9%)
$17.08 M(-10.7%)
Sep 2013
-
$19.14 M(-7.9%)
Jun 2013
-
$20.78 M(+402.1%)
Mar 2013
-
$4.14 M(+28.9%)
Dec 2012
$3.21 M(-50.6%)
$3.21 M(-7.2%)
Sep 2012
-
$3.46 M(-9.3%)
Jun 2012
-
$3.82 M(-23.0%)
Mar 2012
-
$4.96 M(-23.7%)
Dec 2011
$6.50 M(-20.3%)
$6.50 M(+0.1%)
Sep 2011
-
$6.50 M(-24.3%)
Jun 2011
-
$8.58 M(+35.3%)
Mar 2011
-
$6.34 M(-22.2%)
Dec 2010
$8.16 M
$8.16 M(-14.1%)
DateAnnualQuarterly
Sep 2010
-
$9.50 M(-18.8%)
Jun 2010
-
$11.69 M(-12.8%)
Mar 2010
-
$13.40 M(+43.0%)
Dec 2009
$9.37 M(-15.4%)
$9.37 M(-49.8%)
Sep 2009
-
$18.68 M(-53.1%)
Jun 2009
-
$39.82 M(-23.1%)
Mar 2009
-
$51.75 M(+367.1%)
Dec 2008
$11.08 M(-90.8%)
$11.08 M(-85.3%)
Sep 2008
-
$75.40 M(-13.4%)
Jun 2008
-
$87.02 M(-16.1%)
Mar 2008
-
$103.69 M(-14.1%)
Dec 2007
$120.68 M(-34.6%)
$120.68 M(-10.9%)
Sep 2007
-
$135.40 M(-12.5%)
Jun 2007
-
$154.79 M(-2.6%)
Mar 2007
-
$158.90 M(-13.8%)
Dec 2006
$184.41 M(+70.7%)
$184.41 M(-13.1%)
Sep 2006
-
$212.10 M(-8.3%)
Jun 2006
-
$231.29 M(-6.8%)
Mar 2006
-
$248.09 M(+129.6%)
Dec 2005
$108.05 M(+36.3%)
$108.05 M(-4.0%)
Sep 2005
-
$112.56 M(-9.0%)
Jun 2005
-
$123.72 M(-7.8%)
Mar 2005
-
$134.12 M(+69.2%)
Dec 2004
$79.26 M(+37.1%)
$79.26 M(-21.0%)
Sep 2004
-
$100.34 M(-7.5%)
Jun 2004
-
$108.49 M(-9.4%)
Mar 2004
-
$119.72 M(+107.1%)
Dec 2003
$57.81 M(+113.5%)
$57.81 M(+31.9%)
Sep 2003
-
$43.83 M(-10.6%)
Jun 2003
-
$49.03 M(-29.0%)
Mar 2003
-
$69.02 M(+154.9%)
Dec 2002
$27.07 M(-32.2%)
$27.07 M(-15.8%)
Sep 2002
-
$32.14 M(-12.8%)
Jun 2002
-
$36.85 M(+13.7%)
Mar 2002
-
$32.41 M(-18.8%)
Dec 2001
$39.90 M(+87.4%)
$39.90 M(+0.2%)
Sep 2001
-
$39.82 M(+39.1%)
Jun 2001
-
$28.62 M(-19.6%)
Mar 2001
-
$35.59 M(+67.2%)
Dec 2000
$21.29 M(-53.1%)
$21.29 M(-31.8%)
Sep 2000
-
$31.23 M(-18.3%)
Jun 2000
-
$38.22 M(-12.7%)
Mar 2000
-
$43.77 M(-3.6%)
Dec 1999
$45.40 M(-21.6%)
$45.40 M(+0.7%)
Sep 1999
-
$45.10 M(-4.9%)
Jun 1999
-
$47.40 M(-9.9%)
Mar 1999
-
$52.60 M(-9.2%)
Dec 1998
$57.90 M(-13.6%)
$57.90 M(+3.4%)
Sep 1998
-
$56.00 M(-8.9%)
Jun 1998
-
$61.50 M(-4.5%)
Mar 1998
-
$64.40 M(-3.9%)
Dec 1997
$67.00 M(+612.8%)
$67.00 M(-2.9%)
Sep 1997
-
$69.00 M(+287.6%)
Jun 1997
-
$17.80 M(+137.3%)
Mar 1997
-
$7.50 M
Dec 1996
$9.40 M
-

FAQ

  • What is ARCA biopharma annual total assets?
  • What is the all time high annual total assets for ARCA biopharma?
  • What is ARCA biopharma annual total assets year-on-year change?
  • What is ARCA biopharma quarterly total assets?
  • What is the all time high quarterly total assets for ARCA biopharma?
  • What is ARCA biopharma quarterly total assets year-on-year change?

What is ARCA biopharma annual total assets?

The current annual total assets of ABIO is $37.86 M

What is the all time high annual total assets for ARCA biopharma?

ARCA biopharma all-time high annual total assets is $184.41 M

What is ARCA biopharma annual total assets year-on-year change?

Over the past year, ABIO annual total assets has changed by -$5.22 M (-12.12%)

What is ARCA biopharma quarterly total assets?

The current quarterly total assets of ABIO is $33.84 M

What is the all time high quarterly total assets for ARCA biopharma?

ARCA biopharma all-time high quarterly total assets is $248.09 M

What is ARCA biopharma quarterly total assets year-on-year change?

Over the past year, ABIO quarterly total assets has changed by -$4.02 M (-10.61%)